Hrt Financial LP Cidara Therapeutics, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.75 - $1.98 $11,120 - $29,357	14,827 New	14,827 $18,000
Q2 2022 Aug 12, 2022	BUY	$0.43 - $0.91 $4,389 - $9,289	10,208 New	10,208 $4,000
Q4 2021 Feb 14, 2022	SELL	$1.18 - $2.18 $74,535 - $137,701	-63,166 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.48 - $2.35 $58,132 - $92,305	-39,279 Reduced 38.34%	63,166 $141,000
Q2 2021 Aug 16, 2021	BUY	$1.87 - $2.7 $191,572 - $276,601	102,445 New	102,445 $206,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.24B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.